Yi Larson
Director/Board Member at OLEMA PHARMACEUTICALS, INC.
Net worth: - $ as of 31/03/2024
Profile
Ms. Yi Larson is an Independent Director at Olema Pharmaceuticals, Inc. She is on the Board of Directors at Olema Pharmaceuticals, Inc. and Rayzebio, Inc. Ms. Larson was previously employed as a Chief Financial Officer & Executive Vice President by Turning Point Therapeutics, Inc. She received her undergraduate degree from The Wharton School of the University of Pennsylvania, a graduate degree from Massachusetts Institute of Technology and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
LIANBIO
-.--% | 10/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
16/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Yi Larson active positions
Companies | Position | Start |
---|---|---|
OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 06/04/2021 |
Former positions of Yi Larson
Companies | Position | End |
---|---|---|
RAYZEBIO, INC. | Director/Board Member | 26/02/2024 |
LIANBIO | Director of Finance/CFO | 19/12/2023 |
TURG POIN | Director of Finance/CFO | 31/03/2021 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | - |
Training of Yi Larson
Massachusetts Institute of Technology | Graduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
OLEMA PHARMACEUTICALS, INC. | Health Technology |
RAYZEBIO, INC. | Health Technology |
Private companies | 3 |
---|---|
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
LianBio |
- Stock Market
- Insiders
- Yi Larson